![](/img/cover-not-exists.png)
Long-term outcomes of frontline 90 Y-ibritumomab tiuxetan in marginal zone lymphoma
Lossos, Izidore S., Reis, Isildinha M., Rosenblatt, Joseph D., Alderuccio, Juan PabloJournal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1802449
Date:
August, 2020
File:
PDF, 1.17 MB
2020